iShares Exponential Technologies ETF (XT)
49.84
-0.18 (-0.36%)
USD |
NASDAQ |
Jun 27, 16:00
49.84
0.00 (0.00%)
After-Hours: 19:19
Price Chart
Key Stats
Customize
| Expense Ratio | Discount or Premium to NAV | Total Assets Under Management | 30-Day Average Daily Volume |
|---|---|---|---|
| 0.46% | -0.04% | 3.045B | 228507.1 |
| Dividend Yield | Turnover Ratio | 1 Year Fund Level Flows | Max Drawdown (All) |
| 1.00% | 23.00% | 195.54M | Upgrade |
Basic Info
| Investment Strategy | |
| The investment seeks to track the investment results of the Morningstar® Exponential Technologies IndexSM composed of stocks of developed and emerging market companies that create or use exponential technologies. The fund generally will invest at least 80% of its assets in the component securities of the underlying index and in investments that have economic characteristics that are substantially identical to the component securities of the underlying index. The underlying index is a subset of the Morningstar Global Markets Index (the “Parent index”). |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Large Cap/Growth |
| Fixed Income Style | -- |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Category Name | Miscellaneous Sector |
| Category Index | Morningstar US Market TR USD |
| Prospectus Objective | Specialty - Technology |
| Fund Owner Firm Name | iShares |
| Prospectus Benchmark Index | |
| Morningstar Exponential Tech NR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |
| Manager Tenure | |
| Greg Savage | 7.21 yrs |
| Jennifer Hsui | 7.21 yrs |
| Amy Whitelaw | 3.50 yrs |
| Paul Whitehead | 0.41 yrs |
Net Fund Flows Versus Category
1 Month
% Rank:
--
--
Category Low
--
Category High
1 Year
% Rank:
24
195.54M
-307.75M
Category Low
708.87M
Category High
3 Months
% Rank:
--
--
Category Low
--
Category High
3 Years
% Rank:
--
--
Category Low
--
Category High
6 Months
% Rank:
--
--
Category Low
--
Category High
5 Years
% Rank:
--
--
Category Low
--
Category High
YTD
% Rank:
--
--
Category Low
--
Category High
10 Years
% Rank:
--
--
Category Low
--
Category High
As of May 31, 2022
Performance Versus Category
As of June 24, 2022. Returns for periods of 1 year and above are annualized.
Annual Total Returns Versus Peers
As of June 24, 2022.
Asset Allocation
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
|
Sociedad Quimica Y Minera De Chile SA Pfd Registered Shs Series -B-
|
1.03% | -- | -- |
| Jazz Pharmaceuticals PLC | 0.97% | 156.68 | 2.08% |
| Bristol-Myers Squibb Co | 0.94% | 80.00 | 1.32% |
| CF Industries Holdings Inc | 0.92% | 86.81 | 4.19% |
| Mandiant Inc | 0.89% | 21.86 | -0.36% |
| Merck & Co Inc | 0.88% | 94.39 | 1.35% |
|
Shanghai Junshi Biosciences Co Ltd Class A
|
0.88% | -- | -- |
| Exelixis Inc | 0.87% | 22.20 | -0.09% |
| Eli Lilly and Co | 0.87% | 327.18 | 0.48% |
| Ionis Pharmaceuticals Inc | 0.84% | 39.34 | 0.23% |
News
Headline
Wire
Time (ET)
SA Breaking News
06/10 15:04
Basic Info
| Investment Strategy | |
| The investment seeks to track the investment results of the Morningstar® Exponential Technologies IndexSM composed of stocks of developed and emerging market companies that create or use exponential technologies. The fund generally will invest at least 80% of its assets in the component securities of the underlying index and in investments that have economic characteristics that are substantially identical to the component securities of the underlying index. The underlying index is a subset of the Morningstar Global Markets Index (the “Parent index”). |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Large Cap/Growth |
| Fixed Income Style | -- |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Category Name | Miscellaneous Sector |
| Category Index | Morningstar US Market TR USD |
| Prospectus Objective | Specialty - Technology |
| Fund Owner Firm Name | iShares |
| Prospectus Benchmark Index | |
| Morningstar Exponential Tech NR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |
| Manager Tenure | |
| Greg Savage | 7.21 yrs |
| Jennifer Hsui | 7.21 yrs |
| Amy Whitelaw | 3.50 yrs |
| Paul Whitehead | 0.41 yrs |
Fundamentals
| General | |
| Distribution Yield | Upgrade |
| Dividend Yield TTM (6-27-22) | 1.00% |
| 30-Day SEC Yield (4-30-18) | Upgrade |
| 7-Day SEC Yield | -- |
| Number of Holdings | Upgrade |
| Stock | |
| Weighted Average PE Ratio | 20.42 |
| Weighted Average Price to Sales Ratio | Upgrade |
| Weighted Average Price to Book Ratio | Upgrade |
| Weighted Median ROE | Upgrade |
| Weighted Median ROA | Upgrade |
| Forecasted Dividend Yield | Upgrade |
| Forecasted PE Ratio | Upgrade |
| Forecasted Price to Sales Ratio | Upgrade |
| Forecasted Price to Book Ratio | Upgrade |
As of June 23, 2022
Growth Estimates
Fund Details
| Key Dates | |
| Inception Date | 3/19/2015 |
| Last Annual Report Date | 7/31/2021 |
| Last Prospectus Date | 12/20/2021 |
| Attributes | |
| Enhanced Index Fund | No |
| Index Fund |
|
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| Socially Responsible Fund |
|
News
Headline
Wire
Time (ET)
SA Breaking News
06/10 15:04